BPC-157: The Complete Guide to the Most Researched Regenerative Peptide

What Is BPC-157?

BPC-157 stands for Body Protection Compound-157. It is a synthetic peptide consisting of 15 amino acids derived from a naturally occurring protein found in human gastric juice. Originally isolated from the protective lining of the stomach, BPC-157 has become the most extensively studied regenerative peptide in preclinical research, with over 100 published studies examining its effects on tissue repair, inflammation, and organ protection.

Unlike many compounds that target a single pathway, BPC-157 appears to exert its effects through multiple biological mechanisms simultaneously. It influences angiogenesis (the formation of new blood vessels), modulates nitric oxide pathways, interacts with the dopamine and serotonin systems, and promotes the expression of growth factors involved in tissue regeneration.

In February 2026, BPC-157 was restored to Category 1 compounding status by the U.S. Department of Health and Human Services, meaning licensed compounding pharmacies can now legally prepare it with a physician's prescription.

How BPC-157 Works: Mechanism of Action

BPC-157 operates through several interconnected pathways that contribute to its broad regenerative effects.

The peptide upregulates vascular endothelial growth factor (VEGF), which stimulates the formation of new blood vessels at injury sites. This enhanced blood supply delivers oxygen and nutrients critical for tissue repair. Studies have demonstrated accelerated healing in tendons, ligaments, muscles, and even bone tissue following BPC-157 administration.

BPC-157 also modulates the nitric oxide system, which plays a central role in blood flow regulation, immune response, and cellular communication. By maintaining nitric oxide homeostasis, the peptide supports healthy inflammatory responses without suppressing the immune system entirely.

Additionally, BPC-157 interacts with the FAK-paxillin pathway, which governs cell migration and adhesion — two processes essential for wound closure and tissue remodeling. Research has shown that BPC-157 can accelerate the migration of fibroblasts and endothelial cells to damaged areas.

Perhaps most notably for longevity applications, BPC-157 demonstrates cytoprotective effects across multiple organ systems. It has shown protective properties in the gastrointestinal tract, liver, brain, and cardiovascular system in preclinical models.

Key Benefits

The research literature on BPC-157 highlights several primary benefits that make it one of the most versatile compounds in longevity medicine.

Tissue repair and recovery stands as the most well-documented benefit. Studies show accelerated healing of tendons, ligaments, muscles, and bones. Athletes and individuals recovering from injuries report faster return-to-activity timelines when using BPC-157 as part of a physician-supervised protocol.

Gut healing is another major application. Given its origin in gastric juice, BPC-157 has demonstrated remarkable effects on gastrointestinal tissue. Research shows it can counteract damage caused by NSAIDs, alcohol, and stress-related gastric lesions. Many physicians use it as part of gut repair protocols.

Anti-inflammatory activity occurs without the immunosuppressive side effects associated with corticosteroids. BPC-157 modulates the inflammatory response rather than shutting it down, supporting the body's natural healing cascade.

Neuroprotective effects have been observed in preclinical models, with BPC-157 showing interactions with the dopaminergic and serotonergic systems. Some researchers are investigating its potential applications in supporting brain health and neurological recovery.

Dosing Protocol

Typical physician-supervised BPC-157 protocols follow a consistent pattern, though individual dosing should always be determined by a licensed physician based on your specific health profile.

The standard dose ranges from 200 to 500 micrograms (mcg) administered subcutaneously, typically twice daily. Morning and evening dosing is the most common schedule, with many physicians recommending injection near the site of injury for localized tissue repair.

Protocol duration typically runs 4 to 12 weeks, depending on the treatment goal. Acute injury protocols may run shorter, while chronic conditions or gut healing protocols often extend to the full 12-week cycle.

BPC-157 is supplied as a lyophilized (freeze-dried) powder in vials, typically 5mg. It must be reconstituted with bacteriostatic water before injection. Proper reconstitution math is essential — our free Dose Calculator handles this automatically, showing you exact injection volumes, syringe units, and doses per vial.

After reconstitution, BPC-157 should be refrigerated and used within 30 days. Never shake the vial — gently swirl to dissolve the powder.

What the Research Says

The preclinical research base for BPC-157 is extensive. Over 100 studies have been published examining its effects across multiple organ systems and injury types.

A 2020 review in Current Pharmaceutical Design summarized findings across tendon, ligament, muscle, and bone healing models, noting consistent acceleration of repair timelines. The peptide demonstrated significant effects on collagen formation and tissue tensile strength.

Research published in Life Sciences examined BPC-157's cytoprotective effects in the gastrointestinal tract, finding that it counteracted lesions induced by alcohol, NSAIDs, and stress across multiple animal models. The peptide maintained mucosal integrity even under significant chemical challenge.

Studies in the Journal of Physiology-Paris documented BPC-157's interactions with the nitric oxide system and its effects on blood vessel formation. The research showed enhanced angiogenesis at injury sites, correlating with faster tissue repair.

It is important to note that the majority of BPC-157 research has been conducted in animal models. While the preclinical evidence is robust and consistent, large-scale human clinical trials are still needed. This is one reason physician supervision is essential — your doctor can monitor your response and adjust your protocol based on your individual results and bloodwork.

Safety Profile and Side Effects

BPC-157 has demonstrated a favorable safety profile across preclinical studies. No significant toxicity has been reported even at doses substantially higher than those used therapeutically. The peptide has not shown carcinogenic, mutagenic, or organ-toxic effects in the research literature.

The most commonly reported side effects in clinical use are mild and include temporary redness, warmth, or minor discomfort at the injection site. These typically resolve within minutes. Some users report transient nausea or lightheadedness during the first few administrations, which generally diminishes with continued use.

As with any injectable compound, proper sterile technique is important to minimize infection risk. Your physician will provide injection training as part of your protocol onboarding.

Contraindications and interactions should be discussed with your physician. BPC-157 may interact with certain medications, and individuals with active cancer should consult their oncologist before use, given the peptide's angiogenic properties.

Who Should Consider BPC-157

BPC-157 is most commonly prescribed for individuals dealing with acute or chronic soft tissue injuries including tendon and ligament damage, muscle strains and tears, and post-surgical recovery support.

It is also widely used by individuals seeking gut health optimization, particularly those with a history of NSAID use, alcohol-related gastric issues, or chronic digestive inflammation.

Athletes and active individuals use BPC-157 protocols to accelerate recovery between training cycles and support tissue resilience over time.

Within the longevity medicine framework, BPC-157 serves as a foundational recovery compound that pairs well with other peptides. The Recovery Stack — BPC-157 combined with TB-500 — represents the gold standard combination for comprehensive tissue repair.

Getting Started with Physician-Supervised BPC-157

Accessing BPC-157 through Longevity AI follows a straightforward path. Take our Health Quiz to receive a personalized protocol recommendation. If BPC-157 is indicated for your goals and health profile, you can book a physician consultation through our telehealth platform.

Your physician will review your health history, discuss your treatment goals, and customize your protocol. Once approved, your prescription is sent to a licensed compounding pharmacy, and your compounds ship directly to your door within 5-7 business days.

Throughout your protocol, our Progress Tracker lets you log doses, track wellness scores, and journal your experience. Your data informs your next physician check-in, ensuring your protocol evolves with your results.